
Easing — −13% over the month · high confidence, sold-backed · supply thin, sales quiet
The estimate for Scalpel sits at $0.21 — high confidence from 3 of 4 markets, backed by recent sales. It has eased −13% over the last 30 days — behind Commons as a group (−5.3%) and behind the Starter Deck 2: Worst Generation set (0.0%).
Listings and recent sales agree on the level. The Japanese print of the same number trades at about 3.8× this one. Supply on the Japanese market is thin and sales have been quiet this month.
Built from the markets the estimate kept — see how the Atlas Estimate works.